Aroa Biosurgery Limited
AROAF
$0.35
$0.000.00%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.30M | -3.48M | -4.63M | -5.53M | -6.49M |
| Total Depreciation and Amortization | 2.47M | 2.58M | 2.62M | 2.62M | 2.62M |
| Total Amortization of Deferred Charges | 388.00K | 227.20K | 58.40K | 58.40K | 58.40K |
| Total Other Non-Cash Items | 2.22M | 2.67M | 3.03M | 3.21M | 3.38M |
| Change in Net Operating Assets | -4.41M | -4.30M | -4.08M | -4.08M | -4.08M |
| Cash from Operations | -1.63M | -2.30M | -3.01M | -3.73M | -4.51M |
| Capital Expenditure | -1.38M | -1.60M | -1.81M | -1.97M | -2.15M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.78M | 6.65M | 11.56M | 9.91M | 8.33M |
| Cash from Investing | 401.70K | 5.05M | 9.74M | 7.94M | 6.18M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1.01M | -927.00K | -847.00K | -793.50K | -740.00K |
| Issuance of Common Stock | 16.00K | 42.50K | 69.00K | 90.00K | 111.00K |
| Repurchase of Common Stock | -6.00K | -3.00K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -476.00K | -448.50K | -421.00K | -413.00K | -405.00K |
| Cash from Financing | -874.00K | -807.00K | -729.30K | -677.10K | -630.90K |
| Foreign Exchange rate Adjustments | 115.80K | -11.50K | -142.40K | 2.00K | 148.30K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.98M | 1.92M | 5.87M | 3.54M | 1.19M |